Oncorus, Inc.

The momentum for this stock is not very good. Oncorus, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Oncorus, Inc..

News

Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.\n more…

What's Going On With Oncorus (ONCR) Stock Friday?

Benzinga Oncorus, Inc. (NASDAQ: ONCR) shares are soaring Friday on abnormally high volume. The stock appears to be seeing increased attention ahead of the company's impending liquidation. What's Going On:\n more…

Oncorus, Microbot top healthcare gainers; Panbela, Clene among losers

SeekingAlpha.com: All News Oncorus (ONCR) +264%. Microbot Medical (MBOT) +24%. Panbela Therapeutics (PBLA) -52%. Clene (CLNN) -20%.\n more…

After layoffs leave Oncorus a 'shell' of a company, board liquidates the business

FierceBiotech.com - Biotech After layoffs leave Oncorus a shell of a company, board liquidates the business\njwaldron\nMon, 06/12/2023 - 08:54...\n more…

Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket

Benzinga Gainers Auddia Inc. (NASDAQ: AUUD) shares rose 103.2% to $0.8809 in pre-market trading after gaining around 9% on Friday.\n more…

Cancer firm lays off 'substantially all' of its staff, including C-suite

Bizjournals.com - Health Care News Boston cancer firm Oncorus Inc. is laying off "substantially all" of its workforce over the next two months, just six months after shelving its only clinical-stage drug. Oncorus (Nasdaq: ONCR) announced Friday that it was letting go of 55 people in light of its extremely short cash runway: The company only has enough money to fund operations into the third quarter of this year, it said.\n more…